- Home
- NTIC vs PROK Comparison
NTIC vs PROK Comparison
Compare NTIC & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- PROK
- Stock Information
- Founded
- NTIC 1970
- PROK 2015
- Country
- NTIC United States
- PROK United States
- Employees
- NTIC N/A
- PROK N/A
- Industry
- NTIC Industrial Specialties
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTIC Industrials
- PROK Health Care
- Exchange
- NTIC Nasdaq
- PROK Nasdaq
- Market Cap
- NTIC 71.5M
- PROK 85.5M
- IPO Year
- NTIC N/A
- PROK N/A
- Fundamental
- Price
- NTIC $8.46
- PROK $3.37
- Analyst Decision
- NTIC Buy
- PROK Buy
- Analyst Count
- NTIC 1
- PROK 5
- Target Price
- NTIC $20.00
- PROK $6.25
- AVG Volume (30 Days)
- NTIC 82.7K
- PROK 36.0M
- Earning Date
- NTIC 07-10-2025
- PROK 08-08-2025
- Dividend Yield
- NTIC 0.48%
- PROK N/A
- EPS Growth
- NTIC N/A
- PROK N/A
- EPS
- NTIC 0.31
- PROK N/A
- Revenue
- NTIC $85,268,129.00
- PROK $306,000.00
- Revenue This Year
- NTIC $2.05
- PROK $85.21
- Revenue Next Year
- NTIC $4.70
- PROK N/A
- P/E Ratio
- NTIC $26.90
- PROK N/A
- Revenue Growth
- NTIC 3.46
- PROK N/A
- 52 Week Low
- NTIC $6.75
- PROK $0.46
- 52 Week High
- NTIC $15.09
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- NTIC 60.52
- PROK 64.15
- Support Level
- NTIC $7.91
- PROK $3.15
- Resistance Level
- NTIC $8.97
- PROK $7.13
- Average True Range (ATR)
- NTIC 0.51
- PROK 0.92
- MACD
- NTIC 0.09
- PROK 0.32
- Stochastic Oscillator
- NTIC 74.38
- PROK 42.94
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.